SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-031927
Filing Date
2017-05-11
Accepted
2017-05-11 16:32:12
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-8839_110q.htm 10-Q 482133
2 EX-31.1 a17-8839_1ex31d1.htm EX-31.1 14510
3 EX-31.2 a17-8839_1ex31d2.htm EX-31.2 14522
4 EX-32.1 a17-8839_1ex32d1.htm EX-32.1 10310
  Complete submission text file 0001104659-17-031927.txt   2645616

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mdgl-20170331.xml EX-101.INS 507238
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mdgl-20170331.xsd EX-101.SCH 28046
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mdgl-20170331_cal.xml EX-101.CAL 25636
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mdgl-20170331_def.xml EX-101.DEF 85897
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT mdgl-20170331_lab.xml EX-101.LAB 258055
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mdgl-20170331_pre.xml EX-101.PRE 175507
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 17834824
SIC: 2834 Pharmaceutical Preparations